Quince Therapeutics
PublicQuince Therapeutics is now publicly traded
The data on this page reflects Quince Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
May 18, 2026
Total Funding Raised
$134.13M
Company Overview
Quince Therapeutics has raised $134.13M. It was founded in 2012.
Quince Therapeutics is a biotechnology company that acquires, develops, and commercializes therapeutics for debilitating and rare diseases.
AI Layer
Application
Quince Therapeutics Comparables
Compare Quince Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| P2D Bioscience | 33% | |
| Keystone Bio | 32% |
For institutional investors. Book with your work email.
Quince Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | May 18, 2026 | ||||
| Private Placement | Jun 18, 2025 | ||||
| Private Placement | Dec 22, 2015 |
For institutional investors. Book with your work email.
Quince Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Private Placement |
| Balyasny Asset Management L.P. | Private Placement |
| LifeSci Venture Partners | Private Placement |
| Columbia Threadneedle Investments | Private Placement |
| Perceptive Advisors | Private Placement |
| Eventide Funds | Private Placement |
| Coastlands Capital LP | Private Placement |
For institutional investors. Book with your work email.
Quince Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.